These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8255365

  • 1. Monoamine oxidase inhibitors and the cheese effect.
    Anderson MC, Hasan F, McCrodden JM, Tipton KF.
    Neurochem Res; 1993 Nov; 18(11):1145-9. PubMed ID: 8255365
    [Abstract] [Full Text] [Related]

  • 2. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF.
    Vopr Med Khim; 1997 Nov; 43(6):494-503. PubMed ID: 9503566
    [Abstract] [Full Text] [Related]

  • 3. Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
    Benedetti MS, Boucher T, Carlsson A, Fowler CJ.
    Biochem Pharmacol; 1983 Jan 01; 32(1):47-52. PubMed ID: 6830619
    [Abstract] [Full Text] [Related]

  • 4. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS.
    Biokhimiia; 1980 Oct 01; 45(10):1897-908. PubMed ID: 6786369
    [Abstract] [Full Text] [Related]

  • 5. The inhibition of tyramine oxidation and the tyramine hypertensive response ("cheese effect") may be independent phenomena.
    Sandler M, Glover V, Ashford A, Esmail A.
    J Neural Transm; 1980 Oct 01; 48(4):241-7. PubMed ID: 6775051
    [Abstract] [Full Text] [Related]

  • 6. Selective inhibitors of monoamine oxidase type B and the "cheese effect".
    Finberg JP, Gillman K.
    Int Rev Neurobiol; 2011 Oct 01; 100():169-90. PubMed ID: 21971008
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB, Weinstock M.
    Neurotoxicology; 2004 Jan 01; 25(1-2):243-50. PubMed ID: 14697899
    [Abstract] [Full Text] [Related]

  • 8. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS.
    Biokhimiia; 1983 Sep 01; 48(9):1513-21. PubMed ID: 6414536
    [Abstract] [Full Text] [Related]

  • 9. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
    Glover V, Pycock CJ, Sandler M.
    Br J Pharmacol; 1983 Sep 01; 80(1):141-8. PubMed ID: 6418254
    [Abstract] [Full Text] [Related]

  • 10. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 01; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 11. Absence of "cheese effect" during deprenyl therapy: some recent studies.
    Sandler M, Glover V, Ashford A, Stern GM.
    J Neural Transm; 1978 Oct 01; 43(3-4):209-15. PubMed ID: 745013
    [Abstract] [Full Text] [Related]

  • 12. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M, Gorodetsky E, Wang RH, Gross A, Weinreb O, Youdim MB.
    Neuropharmacology; 2002 Nov 01; 43(6):999-1005. PubMed ID: 12423669
    [Abstract] [Full Text] [Related]

  • 13. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM, Masini-Repiso AM, Costamagna ME, Pellizas C, Coleoni AH.
    J Endocrinol; 1994 Nov 01; 143(2):303-8. PubMed ID: 7829993
    [Abstract] [Full Text] [Related]

  • 14. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS, Klimova GI, Nersisian AA.
    Biokhimiia; 1981 Nov 01; 46(11):2043-55. PubMed ID: 6797482
    [Abstract] [Full Text] [Related]

  • 15. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
    Abdo-Rubo A.
    Acta Physiol Hung; 1990 Nov 01; 75(4):321-36. PubMed ID: 2127505
    [Abstract] [Full Text] [Related]

  • 16. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
    Kerecsen L, Bunag RD.
    J Pharmacol Exp Ther; 1989 Nov 01; 251(2):645-9. PubMed ID: 2509682
    [Abstract] [Full Text] [Related]

  • 17. Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'.
    Elsworth JD, Glover V, Reynolds GP, Sandler M, Lees AJ, Phuapradit P, Shaw KM, Stern GM, Kumar P.
    Psychopharmacology (Berl); 1978 Apr 14; 57(1):33-8. PubMed ID: 96466
    [Abstract] [Full Text] [Related]

  • 18. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S, Nahrstedt H, Panten U.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov 14; 324(3):190-5. PubMed ID: 6419132
    [Abstract] [Full Text] [Related]

  • 19. [Properties of intestinal monoamine oxidase in the rat].
    Verevkina IV, Asnina VV, Gorkin VZ.
    Vopr Med Khim; 1982 Nov 14; 28(2):88-93. PubMed ID: 7080482
    [Abstract] [Full Text] [Related]

  • 20. The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?
    Chen JJ, Wilkinson JR.
    J Clin Pharmacol; 2012 May 14; 52(5):620-8. PubMed ID: 21628600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.